Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT05641558

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
  • Nanyang First People's Hospital Nanyang, Henan, China
  • Dermatology Hospital of Jiangxi Province Nanchang, Jiangxi, China
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

NCT04146363

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • Wallace Medical Group, Inc. Beverly Hills, California, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Belle Aimee Skincare Clinic Fountain Valley, California, United States
View all 94 locations
View Trial Details
Completed

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

NCT01995175

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +11 more
Locations
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Santa Clara, California, United States
View all 23 locations
View Trial Details

Related conditions